AKT1 and glioma: Further therapeutic interventions on glioma patients can be designed to specifically downregulate or inhibit effector molecules like Atrogin1 and, specifically, upregulate and activate AKT, as well as efficiently implement nutritional supplementations such as ketogenic diets against glioma cachexia.